Senseonics Secures CE Mark Approval for Eversense 365 CGM System, Expanding EU Market Reach

Senseonics has gained CE Mark approval for its Eversense 365 CGM system, expanding its market reach in the European Union. The company's strategic focus on innovative glucose monitoring solutions positions it well in the healthcare sector. However, Senseonics faces financial challenges, including negative margins and a distressed Altman Z-Score. Despite these challenges, the company expects increased revenue growth in Europe and substantial commercial advancements in both the U.S. and European regions by 2026.